查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566823

血管成形术用气球市场：按类型、应用和最终用户分类：2024-2033 年全球机会分析和产业预测

Angioplasty Balloons Market By Type , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年血管成形术用气球市值为26亿美元，预估2024年至2033年复合年增长率为3.4%，到2033年达到36亿美元。

血管成形术用气球是微创血管内装置，用于打开阻塞或狭窄的血管。该装置可以恢復正常的血流并缓解冠状动脉疾病、心臟病和其他心臟疾病的症状。该手术通常比心臟直视手术便宜，这使其成为许多患者的经济有效的选择。

心血管疾病盛行率的惊人成长推动了全球血管成形术用气球市场的成长。根据世界心臟联盟的数据，心血管疾病是全球第一大死因，超过其他原因。每年约有 2050 万人死于心血管疾病。其中，85%是由于心臟疾病（如心臟病）和脑血管疾病（如中风）引起的。此外，老年人口的增加对市场成长做出了重大贡献。这是因为老年人更容易罹患心臟疾病。根据西班牙心臟学会官方刊物Revista Espanola de Cardiologia发表的论文，心臟疾病是65岁以上成年人81%的死亡原因。此外，血管成形术等微创手术因其恢復速度更快、住院时间更短而受到患者和医疗保健提供者的青睐，从而推动了市场成长。然而，血管成形术的高成本以及与血管成形术相关的併发症（例如动脉夹层和血管再阻塞）正在阻碍市场成长。同时，球囊设计、材料和成像技术的不断改进提高了血管成形术的有效性和安全性，预计将为预测期内的市场扩张提供有利的机会。

血管成形术用气球的全球市场按类型、应用、最终用户和地区进行细分。依类型分为一般气球、药物释放型球囊、切割球囊、球囊导管。依用途分为週边动脉和冠状动脉。根据最终用户，它分为 ASC、医院和导管实验室。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按类型划分，一般气球细分市场是 2023 年的主要收益来源。

从应用来看，2023年冠状动脉段在血管成形术用气球市场中占据最大份额。

以最终用户计算，ASC 细分市场将在 2023 年成为主要股东。

按地区划分，预计北美将在 2023 年产生最高收益，并在预测期内主导市场。

该报告可以定制。

  • 根据客户兴趣加入公司简介

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章血管成形术用气球市场：依类型

  • 市场概况
  • 一般气球
  • 药物释放型球囊
  • 切割球囊
  • 球囊导管

第五章血管成形术用气球市场：依应用分类

  • 市场概况
  • 週边
  • 冠状动脉

第六章血管成形术用气球市场：依最终用户分类

  • 市场概况
  • 造血干细胞
  • 医院
  • 导管实验室

第七章血管成形术用气球市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国血管成形术用气球市场
    • 加拿大血管成形术用气球市场
    • 墨西哥血管成形术用气球市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国血管成形术用气球市场
    • 德国血管成形术用气球市场
    • 义大利血管成形术用气球市场
    • 西班牙血管成形术用气球市场
    • 英国血管成形术用气球市场
    • 其他欧洲血管成形术用气球市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国血管成形术用气球市场
    • 日本血管成形术用气球市场
    • 印度血管成形术用气球市场
    • 韩国血管成形术用气球市场
    • 澳洲血管成形术用气球市场
    • 其他亚太血管血管成形术用气球市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西血管成形术用气球市场
    • 南非共和国血管成形术用气球市场
    • 沙乌地阿拉伯血管成形术用气球市场
    • 其他拉丁美洲/中东/非洲血管成形术用气球市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE And Co. KG
  • Boston Scientific Corporation
  • CR Bard, Inc.
  • Cardinal Health, Inc
  • MEDTRONIC PLC.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • THE SPECTRANETICS CORPORATION
简介目录
Product Code: A38595

The angioplasty balloons market was valued at $2.6 billion in 2023, and is projected to reach $3.6 billion by 2033, growing at a CAGR of 3.4% from 2024 to 2033.

Angioplasty balloon is a minimally invasive endovascular device is used to open up blocked or narrowed blood vessels. This device enables to restore proper blood flow, alleviating the symptoms of coronary artery disease, heart attacks, and other cardiac diseases. The procedure is generally less expensive than open heart surgery, making it a cost-effective option for many patients.

The growth of the global angioplasty balloons market is driven by alarming increase in prevalence of cardiovascular diseases. According to the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared to any other cause. Approximately 20.5 million die every year due to cardiovascular diseases. Of these deaths, 85% are due to coronary heart diseases (e.g., heart attacks) and cerebrovascular diseases (e.g., strokes). Moreover, increase in geriatric population significantly contributes toward the growth of the market. This is attributed to the fact that aged individuals are highly susceptible to cardiac diseases. As per the article published by the Revista Espanola de Cardiologia-the official publication of the Spanish Society of Cardiology-coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in preference for minimally invasive procedures among patients and healthcare providers like angioplasty due to quicker recovery times and reduced hospital stays foster the growth of the market. However, high cost of angioplasty and complications associated with angioplasty, such as arterial dissection or restenosis hamper the market growth. On the contrary, continuous improvements in balloon design, materials, and imaging technologies will enhance the efficacy and safety of angioplasty procedures, which are expected to offer remunerative opportunities for the expansion of the market during the forecast period.

The global angioplasty balloons market is segmented into type, application, end user, and region. On the basis of type, the market is classified into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. By application, it is bifurcated into peripheral and coronary. Depending on end user, it is segregated into ASCs, hospitals, and Cath labs. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the normal balloon segment was the major revenue generator in 2023.

By application, the coronary segment accounted for the largest share in 2023 in angioplasty balloons market.

Depending on end user, the ASCs segment held the was the key shareholder in 2023.

Region wise, North America generated the highest revenue in 2023 and is expected to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global angioplasty balloons market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc, MEDTRONIC PLC., MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Type

  • Normal Balloons
  • Drug Eluting Balloons
  • Cutting Balloons
  • Scoring Balloons

By Application

  • Peripheral
  • Coronary

By End User

  • ASCs
  • Hospitals
  • Cath Labs

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • C. R. Bard, Inc.
    • Cardinal Health, Inc
    • MEDTRONIC PLC.
    • MicroPort Scientific Corporation
    • Terumo Corporation
    • THE SPECTRANETICS CORPORATION

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ANGIOPLASTY BALLOONS MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Normal Balloons
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Drug Eluting Balloons
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Cutting Balloons
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Scoring Balloons
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Peripheral
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Coronary
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: ANGIOPLASTY BALLOONS MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. ASCs
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Hospitals
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Cath Labs
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ANGIOPLASTY BALLOONS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Angioplasty Balloons Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Angioplasty Balloons Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Angioplasty Balloons Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Angioplasty Balloons Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Angioplasty Balloons Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Angioplasty Balloons Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Angioplasty Balloons Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Angioplasty Balloons Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Angioplasty Balloons Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Angioplasty Balloons Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Angioplasty Balloons Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Angioplasty Balloons Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Angioplasty Balloons Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Angioplasty Balloons Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Angioplasty Balloons Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Angioplasty Balloons Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Angioplasty Balloons Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Angioplasty Balloons Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Angioplasty Balloons Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. B. Braun Melsungen AG
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Biotronik SE And Co. KG
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Boston Scientific Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. C. R. Bard, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Cardinal Health, Inc
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. MEDTRONIC PLC.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. MicroPort Scientific Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Terumo Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. THE SPECTRANETICS CORPORATION
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments